Bio-Techne
TECH
#1486
Rank
S$15.75 B
Marketcap
$99.15
Share price
2.49%
Change (1 day)
-3.82%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of September 2024 : S$0.54 Billion

According to Bio-Techne's latest financial reports the company's total debt is S$0.54 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2024)

Total debt by year

Year Total debt Change
2023-06-30S$0.61 B35.92%
2022-06-30S$0.45 B-19.73%
2021-06-30S$0.56 B-6.38%
2020-06-30S$0.60 B-11.61%
2019-06-30S$0.68 B47.91%
2018-06-30S$0.46 B-2.5%
2017-06-30S$0.47 B269.42%
2016-06-30S$0.12 B23.64%
2015-06-30S$0.10 B541.23%
2014-06-30S$16.17 M
2006-06-30S$21.24 M-13.73%
2005-06-30S$24.62 M-9.75%
2004-06-30S$27.28 M-9.04%
2003-06-30S$29.99 M-5.97%
2002-06-30S$31.9 M-7.55%
2001-06-30S$34.51 M0.99%
2000-06-30S$34.17 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
S$47.85 B 8,752.20%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.88 B 247.97%๐Ÿ‡บ๐Ÿ‡ธ USA
S$27.25 B 4,941.14%๐Ÿ‡บ๐Ÿ‡ธ USA
S$23.74 B 4,292.88%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.60 B 381.26%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
S$26.99 B 4,894.01%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.75 M-99.12%๐Ÿ‡บ๐Ÿ‡ธ USA